Provided by Tiger Fintech (Singapore) Pte. Ltd.

Werewolf Therapeutics, Inc.

0.8544
-0.0198-2.26%
Volume:82.35K
Turnover:70.93K
Market Cap:38.30M
PE:-0.52
High:0.9080
Open:0.9000
Low:0.8331
Close:0.8742
Loading ...
Apr 15, 2022

Major Issues Report

8-K - Current report
Apr 07, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 10, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 02, 2021

Major Issues Report

8-K - Current report
May 28, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 14, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 13, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 10, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership